Indian data regarding serious neurological and psychiatric adverse events, following
coronavirus disease 2019 (COVID-19) vaccination, are lacking. We, therefore, systematically …

Vaccination is an effective means to contain the spread of COVID-19 infection. While data on
the safety of COVID-19 vaccines remain limited in patients with leprosy, there have been a …

Background Individuals with leprosy are at risk of leprosy reactions, T-cell mediated
immunological complications, which lead to nerve function impairment. Leprosy reactions …

Dear Editor, The vaccination against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) continues to expand across the globe. Concurrently, a large number of …

Currently, over 200,000 new cases of leprosy are reported annually worldwide. Although
leprosy was thought to have been eradicated in Taiwan, a few new cases still occur …

Abstract Dear Editor, Leprosy is an important infectious disease that poses a threat to a
substantial number of patients. Clinicians have reported various cutaneous adverse …

Background: Leprosy reactions are the main pathway leading to severe nerve damage and
disability. These reactions can occur at any time. The coronavirus disease 2019 (Covid-19) …

Cutaneous manifestations post-Covid-19 vaccination have been well documented in
literature. However, exacerbation of underlying chronic dermatoses following COVID-19 …

Erythema nodosum leprosum (ENL) is an immune complex mediated type III hypersensitivity
reaction seen in patients of borderline lepromatous and lepromatous leprosy. It can be …

COVID-19 pandemic has put the world in a stand still and, with the current vaccination drive
globally to combat the disease, many adverse effects have been reported in the literature …